Risk-of-Bias Assessment of Target Trial Emulation Studies at Regulatory and Policy Decision Points Along the Medical Product Life Cycle: Protocol for a Scoping Review and Stakeholder Survey

Risk-of-Bias Assessment of Target Trial Emulation Studies at Regulatory and Policy Decision Points Along the Medical Product Life Cycle: Protocol for a Scoping Review and Stakeholder Survey

Authors of this article:

Anni Kokolahti¹ ;   Saara Puustinen¹ ;   Martin Russek² ;   Christoph Röthlein² ;   Cornelia Becker² ;   Jonas Peltner² ;   Ines Costa³ ;   Sirpa Hartikainen¹ ;   Britta Haenisch^{2, 4, 5} ;   Cláudia Furtado^{3, 6} ;   Anna-Maija Tolppanen¹ ;   Christina Tikka¹